Experience in the use of drugs of the «WALA» company in an obstetrics and gynecology hospital

Heinz N.Y.

Головна
Публікації
Experience in the use of drugs of the «WALA» company in an obstetrics and gynecology hospital

3 листопада 2022

936

Obstetrics and Gynecology

Heinz N.Y.

Ключові слова :

Apis/Belladonna cum Mercury,

Calcium Quercus Globuli velati,

Meteoric Iron Globuli velati,

pelvic inflammatory disease

Спеціальності :

Obstetrics and Gynecology

Резюме

Objective: to compare the effectiveness of the improved treatment algorithm with the classical scheme of therapy for pelvic inflammatory disease (PID).

Object and research methods. The study involved 48 patients undergoing inpatient treatment with PID. Women of the 1st group (n=24) received classical treatment (combined antibacterial therapy and non-steroidal anti-inflammatory drugs), the 2nd (n=24) — received treatment according to an improved algorithm with the use of the drugs Calcium Quercus Globuli velati, Meteoric Iron Globuli velati and Apis/Belladonna cum Mercury.

Results. In the 1st group, the duration of stay of patients in the hospital was 10.50±0.77 days, in the 2nd — 9.17±0.69 (p<0,05). The dynamics of the indicator of the total number of leukocytes was significantly better in patients who underwent treatment according to the improved algorithm.

Conclusion. The combined therapy of PID, which additionally includes the drugs Calcium Quercus Globuli velati, Meteoric Iron Globuli velati and Apis/Belladonna cum Mercury, allows to achieve better indicators of clinical effectiveness in comparison with the classical scheme of therapy.

References

Доброхотова Ю.Э., Бондаренко К.Р., Дворников А.С. (2016) Современные представления о воспалительных процессах органов малого таза. Гинекология, 18(3): 4–8.
Бенюк В.А., Ластовецкая Л.Д., Усевич И.А. и др. (2008) Современные подходы к диагностике и лечению воспалительных заболеваний придатков матки. Здоровье женщины, 2(34): 67–70.
Корнацька А.Г., Вовк І.Б., Чубей Г.В. (2012) Запальні захворювання органів малого таза, спричинені інфекціями, що передаються статевим шляхом. Здоров’я України, 4: 38–39.
Ventskivska I.B., Zhabitska L.A., Vitovskyi Y.M., Ventskivskyi, K.O. (2018) Післяопераційні спайки як проблема репродукції та шляхи ix попередження. Актуальні питання педіатрії, акушерства та гінекології: https://doi.org/10.11603/24116-4944.2008.1.9483
Jennings L.K., Krywko D.M. (2022) Pelvic Inflammatory Disease. StatPearls Publishing.
Kimura F., Takebayashi A., Ishida M. et al. (2019) Chronic endometritis and its effect on reproduction. J. Obstet. Gynaecol. Res., 45(5): 951–960. doi: 10.1111/jog.13937.
Puente E., Alonso L., Laganà A.S. et al. (2020) Chronic Endometritis: Old Problem, Novel Insights and Future Challenges. Int. J. Fertil. Steril., 13(4): 250–256. doi: 10.22074/ijfs.2020.5779.
Lainez N.M., Coss D. (2019) Obesity, Neuroinflammation, and Reproductive Function. Endocrinology, 160(11): 2719–2736. doi: 10.1210/en.2019-00487.
Bindu S., Mazumder S., Bandyopadhyay U. (2020) Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem. Pharmacol., 180: 114147. doi: 10.1016/j.bcp.2020.114147.
Harirforoosh S., Asghar W., Jamali F. (2013) Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J. Pharm. Sci., 16(5): 821–847. doi: 10.18433/j3vw2f. PMID: 24393558.